Gubra AS (FRA:PI3) Other Operating Expense: €12.2 Mil (TTM As of Dec. 2025)


FRA:PI3 Gubra AS FRA:PI3
78 GF Score
Price €48.02
GF Value €386.57
Valuation Possible Value Trap
! 3 Warning Signs
View Full Analysis

What is Gubra AS Other Operating Expense?

Gubra AS FRA:PI3 -0.62% 78 Other Operating Expense is €12.2 Mil as of Dec. 2025. GuruFocus rates FRA:PI3 with a GF Score™ of 78/100 and a GF Value™ of €386.57 (Possible Value Trap). The stock has 3 warning signs investors should review.

Gubra AS's Other Operating Expense for the six months ended in Dec. 2025 was €12.2 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 was €12.2 Mil.

Gubra AS's quarterly Other Operating Expense declined from Dec. 2024 (€7.2 Mil) to Jun. 2025 (€-0.0 Mil) but then increased from Jun. 2025 (€-0.0 Mil) to Dec. 2025 (€12.2 Mil).

Gubra AS's annual Other Operating Expense increased from Dec. 2023 (€9.8 Mil) to Dec. 2024 (€13.6 Mil) and increased from Dec. 2024 (€13.6 Mil) to Dec. 2025 (€22.5 Mil).

Gubra AS Other Operating Expense Historical Data

* Premium members only.

The historical data trend for Gubra AS's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Gubra AS Other Operating Expense Chart

Gubra AS Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Operating Expense
Get a 7-Day Free Trial 6.74 5.67 9.85 13.61 22.46

Gubra AS Semi-Annual Data
Dec19 Dec20 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Other Operating Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 5.02 0.03 7.19 -0.02 12.24
FRA:PI3
78GF Score
Gubra AS FRA:PI3
Other Operating Expense is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Gubra AS Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was €12.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

What does a Other Operating Expense of €12.2 Mil mean?
Gubra AS (FRA:PI3) has a Other Operating Expense of €12.2 Mil as of Dec. 2025. Other operating expenses that a company records on its income statement. View historical data on Gubra AS and its competitors.
Is Gubra AS's Other Operating Expense too high?
Gubra AS's current Other Operating Expense is €12.2 Mil. Overall, Gubra AS has a GF Score™ of 78/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Gubra AS's Other Operating Expense compare to VRTX and REGN?
Gubra AS's Other Operating Expense of €12.2 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Operating Expense for a Biotechnology company?
A good Other Operating Expense depends on the Biotechnology industry context. However, Other Operating Expense should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Operating Expense mean?
A high Other Operating Expense can signal that a stock is expensive relative to its fundamentals. Other operating expenses that a company records on its income statement. View historical data on Gubra AS and its competitors. Gubra AS's current Other Operating Expense is €12.2 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Gubra AS stock overvalued right now?
Based on GuruFocus' analysis, Gubra AS (FRA:PI3) is currently considered Possible Value Trap. The stock's GF Value™ is €386.57, compared to a current price of €48.02 — trading 87.6% below its estimated fair value. The current Other Operating Expense is €12.2 Mil. Gubra AS's overall GF Score™ is 78/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Operating Expense calculated?
Other Operating Expense is calculated from a company's financial statements. For Gubra AS (FRA:PI3), the current Other Operating Expense is €12.2 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Gubra AS (FRA:PI3) Overvalued in 2026?

Based on GuruFocus' analysis, Gubra AS stock appears to be undervalued. The current stock price of €48.02 is trading 87.6% below its estimated GF Value™ of €386.57. GuruFocus considers Gubra AS to be Possible Value Trap.

Key valuation signals for FRA:PI3:

  • Other Operating Expense: €12.2 Mil
  • GF Value™: €386.57 vs. price of €48.02 (87.6% below fair value)
  • GF Score™: 78/100 with 3 warning signs

No single metric tells the full story. See the FRA:PI3 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Gubra AS Business Description

Other Exchanges GUBRA:DenmarkPI3:Germany
Address Horsholm Kongevej 11B, Horsholm, DNK, 2970
Gubra AS is a specialized preclinical CRO and biotech company focused on peptide-based drug discovery within metabolic and fibrotic diseases. The company has two segments: Pre-clinical contract research (CRO), which derives maximum revenue and Biotech Segment. It derives maximum revenue from Pre-clinical contract research (CRO) segment. Geographically, the company operates in Europe, North America and Other regions.
78GF Score

Get the complete analysis for FRA:PI3

Other Operating Expense is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€48.02
Price
€386.57
GF Value